Conmed Corp (CNMD) Q3 2024 Earnings Call Highlights: Strong U.S. ...

Conmed Corp (CNMD) Q3 2024 Earnings Call Highlights: Strong U.S. ...

The general surgery segment underperformed due to a strong prior year quarter and circuit board availability issues affecting sales. Orthopedic supply chain challenges are being addressed despite setbacks, aiming to improve manufacturing and vendor supply chains. Conmed anticipates growth in 2025, focusing on revitalizing revenue.

Read More

Did you find this insightful?